Enanta Pharmaceuticals Stock News

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Investment analysts at Piper Sandler decreased their FY2025 earnings per share (EPS) estimates for Enanta Pharmaceuticals in a research report issued on Monday, November 22nd. Piper Sandler analyst Y. Rahimi now anticipates that the biotechnology company will post earnings per share of $25.29 for the year, down from their prior []

Enanta Pharmaceuticals (NASDAQ:ENTA) had its target price upped by Oppenheimer from $55.00 to $73.00 in a research report released on Wednesday morning, The Fly reports. The firm currently has a market perform rating on the biotechnology companys stock. A number of other analysts have also weighed in on the stock. JMP Securities increased their price []

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Investment analysts at Piper Sandler dropped their FY2025 earnings per share estimates for Enanta Pharmaceuticals in a report released on Monday, November 22nd. Piper Sandler analyst Y. Rahimi now expects that the biotechnology company will post earnings of $25.29 per share for the year, down from their previous forecast of []

Enanta Pharmaceuticals Inc (NASDAQ:ENTA) stock surges 12.45% (As on Nov 23, 11:57:54 AM UTC-4, Source: Google Finance) after the company posted mixed results for the The post Enanta Pharmaceuticals Inc (NASDAQ:ENTA) beaten the earnings estimates appeared first on FXDailyReport.Com .

Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) gapped up before the market opened on Tuesday . The stock had previously closed at $75.18, but opened at $77.96. Enanta Pharmaceuticals shares last traded at $81.51, with a volume of 797 shares changing hands. A number of research analysts have weighed in on ENTA shares. Robert W. Baird []

The stock price of Enanta Pharmaceuticals Inc (NASDAQ: ENTA) increased by over 10% during intraday trading today. This is why it happened.

Enanta Pharmaceuticals, Inc. (ENTA) has reported mixed results for the fourth quarter of Fiscal Year 2021 (ended September 30, 2021). The post Enantas Q4 Loss Meets Expectations appeared first on Smarter Analyst .

Wall Street brokerages expect that Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) will announce earnings of ($1.31) per share for the current fiscal quarter, Zacks reports. Six analysts have issued estimates for Enanta Pharmaceuticals earnings. The highest EPS estimate is ($0.60) and the lowest is ($1.59). Enanta Pharmaceuticals posted earnings of ($0.55) per share during the same quarter []

ENTA earnings call for the period ending September 30, 2021.

Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of 6.87% and 33.87%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the sto

Enanta Pharmaceuticals, Inc. (ENTA) CEO Dr. Jay Luly on Q4 Fiscal 2021 Result - Earnings Call Transcript

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2021

Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of 6.87% and 33.87%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the sto